Christina M. Ackermann
2018
Compensation breakdown
| Non-Equity Incentive Plan | $892,320 |
|---|---|
| Option Awards | $359,964 |
| Salary | $647,539 |
| Stock Awards | $723,176 |
| Other | $763,908 |
| Total | $3,386,907 |
Ackermann received $892.3K in non-equity incentive plan, accounting for 26% of the total pay in 2018.
Ackermann also received $360K in option awards, $647.5K in salary, $723.2K in stock awards and $763.9K in other compensation.
Rankings
In 2018, Christina M. Ackermann's compensation ranked 3,373rd out of 14,244 executives tracked by ExecPay. In other words, Ackermann earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,373 out of 14,244 | 76th |
Division Manufacturing | 1,245 out of 5,765 | 78th |
Major group Chemicals And Allied Products | 435 out of 2,128 | 80th |
Industry group Drugs | 358 out of 1,817 | 80th |
Industry Pharmaceutical Preparations | 275 out of 1,391 | 80th |
Pay ratio
| Christina M. Ackermann's Pay | $3,386,907 |
|---|---|
| Median Employee's Pay | $37,872 |
| Pay Ratio | 89to 1 |
In 2018, the annual total compensation of Christina M. Ackermann was $3,386,907.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.
The ratio of Christina M. Ackermann's pay to the pay of median employee was therefore 89 to one.
Ackermann's colleagues
We found four more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2018.
2018
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2018
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2018
Thomas Appio
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
2018
Joseph Gordon
Valeant Pharmaceuticals International